Pulmonary Artery Hypertension Patients and the Coronavirus Disease of 2019 (COVID-19): Are They Protected from Severe Disease?



Anggoro Budi Hartopo(1*), Dyah Wulan Anggrahini(2), Bambang Budi Siswanto(3), Lucia Kris Dinarti(4)

(1) Universitas Gadjah Mada
(2) 
(3) 
(4) 
(*) Corresponding Author

Abstract


The coronavirus disease of 2019 (COVID-19) is a current pandemic of viral infection which mainly involve respiratory system and may progress into severe multiple organ dysfunction and mortality. Pulmonary artery hypertension (PAH) is considered to be not in greater risk to develop severe COVID-19. However, whether this population is protected from severe COVID-19 is unclear. There are protective and offensive factors need to be considered in PAH patients in respect to COVID-19.

Keywords


COVID-19; pulmonary artery hypertension; severity





Article Metrics

Abstract views : 66




Copyright (c) 2020 Journal of the Medical Sciences (Berkala ilmu Kedokteran)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

View My Stats

 

Creative Commons License
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) by  Universitas Gadjah Mada is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://jurnal.ugm.ac.id/bik/.